In addition it addresses the FDA’s communications with the applicant, the retention of documents that aid the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of an SE report to a different applicant and electronic submission on the SE report and amendments.